Enabling every cure for community matters: Our AI-powered journey
As we move through 2024, I’m thrilled with the extraordinary work our team is doing to change how we finance drug development: from funding next-generation therapies to helping others identify the highest potential cures in their development pipelines.
Revolutionizing Drug Development for Rare Diseases Through AI | Alok Tayi
“In this episode, Alok shares his personal story of how medical conditions in his family led to the creation of Vibe Bio, and how the company aims to identify diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures.”
Developing a Small Molecule for Duchenne Muscular Dystrophy with Frank Gleeson | VibeCast Episode 48
In this episode, VibeCast host Ray Dogum speaks with Frank Gleeson, Co-Founder and CEO of Satellos Bioscience, about groundbreaking small molecule therapies for Duchenne muscular dystrophy. Frank Gleeson’s journey into the world of small molecule therapy for Duchenne muscular dystrophy is a testament to the power of unexpected paths and unwavering determination. Growing up with […]
The Biotech Startups Podcast with guest Alok Tayi, Founder & CEO of Vibe Bio
Watch the 3 part podcast episode on YouTube! We are proud to share a recent The Biotech Startups Podcast episode hosted by Jon Chee, CEO of Excedr. In the episode, Jon and Alok discuss the many opportunities that can improve the biotech industry and how Vibe Bio is tackling the problem of funding & guiding […]
STAT – Upending drug industry financing
Allison DeAngelis authored an article, featuring Vibe Bio CEO, Alok Tayi, on ‘decentralized science’ which seeks to upend drug industry financing. The article detailed Alok’s journey to founding Vibe Bio. “The experience stuck with Tayi, who is a scientist and entrepreneur, and led him to co-found a new organization that’s designed to allow patients, scientists, […]
Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands
John Cumbers authored an article featuring Alok Tayi’s new start-up, Vibe Bio. “In short, the contours of drug development are defined around inflection points — the kinds of milestones that serve as “power-ups” to move a company to the next level of funding and scientific research by increasing a company’s valuation and strategically informing what […]
Endpoint News – Parents become drug developers to save their children’s lives
Endpoint News editor, Jared Whitlock, featured our CEO, Alok Tayi, in an article on how parents of children with rare disease are challenging the status quo in drug development. “The challenge for rare diseases isn’t necessarily finding a treatment — it’s funding it,” said Alok Tayi, CEO and co-founder of Vibe Biotechnology” Read the full […]
Coindesk – How Vibe Bio plans to retool biotech funding
David Z. Morris authored an article on Decentralized Autonomous Organizations for funding research for diseases. In the article, our founder and CEO, Alok Tayi, explains how a decentralized science approach can accelerate biotech funding opportunities. “The obstacle for all of us was that there wasn’t the funding to advance research. The challenge in finding a […]
The Scoop – A conversation with Alok Tayi
Episode 58 of Season 4 of The Scoop was recorded remotely with The Block’s Frank Chaparro and Alok Tayi, Co-Founder & CEO of Vibe Bio. “In this episode of The Scoop, Tayi shares his vision for how Vibe Bio aims to disrupt the centralized control of big pharma” You can read a full summary and […]
